Connect
MJA
MJA

Misleading information for consumers

David Torpy
Med J Aust 2007; 186 (9): 483-484.
Published online: 7 May 2007

To the Editor: I concur with Professor Stockigt’s recent article1 outlining the shortcomings of product information (PI) for thyroid-related drugs. I often need to contradict incorrect or even hazardous PI advice given to patients.

  • David Torpy

  • Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA.

Correspondence: dtorpy@mail.rah.sa.gov.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.